Skip to main content
Premium Trial:

Request an Annual Quote

Zyomyx Promotes COO to CEO, Appoints CFO

NEW YORK, Feb 5 - Zyomyx, a Hayward, Calif.-based protein chip company, said Monday that Lawrence Cohen, the company’s chief operating officer, had been promoted to CEO.

The company also named Garrett Roper chief financial officer.

Cohen will replace Yasunori Kaneko, who has been CEO since 1998. Kaneko will stay on as chairman of Zyomyx’s board.

A spokeswoman for Zyomyx said that Kaneko had been working as a part-time CEO and that Cohen’s promotion to CEO reflected the his effectiveness as COO.

Zyomyx, which has an agreement with Cambridge Antibody Technology to jointly develop high-density protein chips, is scheduled to begin beta testing its protein chips sometime in the first half of this year. Other companies currently developing protein arrays include Motorola, Proteome Systems, Protein Sciences Corporation, HTS Biosystems, Oxford Glycosciences, Phylos, and Packard Biosciences.

The privately-held company recently raised $32.6 million in private financing.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.